Survival in cats with primary and secondary cardiomyopathies.

J Feline Med Surg

The Cardiology Unit; Department of Veterinary Sciences and Public Health (DIVET), Università degli Studi di Milano, Milan, Italy.

Published: June 2016

Objectives: Feline cardiomyopathies (CMs) represent a heterogeneous group of myocardial diseases. The most common CM is hypertrophic cardiomyopathy (HCM), followed by restrictive cardiomyopathy (RCM). Studies comparing survival and outcome for different types of CM are scant. Furthermore, little is known about the cardiovascular consequences of systemic diseases on survival. The aim of this retrospective study was to compare survival and prognostic factors in cats affected by HCM, RCM or secondary CM referred to our institution over a 10 year period.

Methods: The study included 94 cats with complete case records and echocardiographic examination. Fifty cats presented HCM, 14 RCM and 30 secondary CM.

Results: A statistically significant difference in survival time was identified for cats with HCM (median survival time of 865 days), RCM (273 days) and secondary CM (<50% cardiac death rate). In the overall population and in the primary CM group (HCM + RCM), risk factors in the multivariate analysis, regardless of the CM considered, were the presence of clinical signs, an increased left atrial to aortic root (LA/Ao) ratio and a hypercoagulable state.

Conclusions And Relevance: Primary CMs in cats share some common features (ie, LA dimension and hypercoagulable state) linked to feline cardiovascular physiology, which influence survival greatly in end-stage CM. The presence of clinical signs has to be regarded as a marker of disease severity, regardless of the underlying CM. Secondary CMs are more benign conditions, but if the primary disease is not properly managed, the prognosis might also be poor in this group of patients.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11185237PMC
http://dx.doi.org/10.1177/1098612X15588797DOI Listing

Publication Analysis

Top Keywords

cats hcm
8
hcm rcm
8
rcm secondary
8
survival time
8
survival
6
survival cats
4
cats primary
4
secondary
4
primary secondary
4
secondary cardiomyopathies
4

Similar Publications

Introduction: Cardiogenic arterial thromboembolism (CATE) is a life-threatening complication of hypertrophic cardiomyopathy (HCM) with a high mortality rate. As the primary responders in hemostasis, platelets play a crucial role in the progression of CATE. Procoagulant platelets are a subpopulation of activated platelets that facilitate thrombin generation to strengthen thrombus structure.

View Article and Find Full Text PDF

The aim of this study was to evaluate the association between spontaneous echocardiographic contrast (SEC) and left atrial (LA) parameters such as size, volume, and function in cats with hypertrophic cardiomyopathy (HCM). Cats were assigned into following groups: clinically healthy cats (n=8), HCM without SEC (n=12), and HCM with SEC (n=8). Left atrial shortening fraction (LAFS%) and left atrial fractional area change (LAFAC) had statistical significance between groups.

View Article and Find Full Text PDF

Hypertrophic cardiomyopathy (HCM) afflicts humans, cats, pigs, and rhesus macaques. Disease sequelae include congestive heart failure, thromboembolism, and sudden cardiac death (SCD). Sarcomeric mutations explain some human and cat cases, however, the molecular basis in rhesus macaques remains unknown.

View Article and Find Full Text PDF

Background: Hypertrophic cardiomyopathy (HCM) is a common heritable heart disease where the most frequently associated mutations occur in the myosin-binding protein C () sarcomere-associated gene. HCM is also a common veterinary clinical problem in certain cat breeds such as Maine Coons and Ragdolls, also most associated with mutations in . Mouse models of HCM in which mutations are introduced recapitulate some, but not all, features of human HCM.

View Article and Find Full Text PDF
Article Synopsis
  • Hypertrophic cardiomyopathy (HCM) is a common heart condition in cats, leading to heart failure due to diastolic dysfunction, and can be classified as obstructive or non-obstructive based on whether there's an obstruction in the outflow tract.
  • Recent research focused on using color M-mode (CMM) to measure intraventricular pressure differences (IVPD) and create an intraventricular pressure gradient (IVPG) index to assess diastolic impairment non-invasively in cats with obstructive HCM.
  • The findings indicated that while there was no severe left atrial enlargement in cats with obstructive HCM, the IVPG was significantly higher compared to control cats, suggesting elevated left
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!